ZYDUS PHARMS USA INC FDA Approval ANDA 213064

ANDA 213064

ZYDUS PHARMS USA INC

FDA Drug Application

Application #213064

Documents

Letter2022-12-20

Application Sponsors

ANDA 213064ZYDUS PHARMS USA INC

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002
None (Tentative Approval)003

Application Products

001TABLET;ORAL15MG0EDOXABANEDOXABAN
002TABLET;ORAL30MG0EDOXABANEDOXABAN
003TABLET;ORAL60MG0EDOXABANEDOXABAN

FDA Submissions

UNKNOWN; ORIG1TA2022-11-16STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

ZYDUS PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213064
            [companyName] => ZYDUS PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"EDOXABAN","activeIngredients":"EDOXABAN","strength":"15MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"EDOXABAN","activeIngredients":"EDOXABAN","strength":"30MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"EDOXABAN","activeIngredients":"EDOXABAN","strength":"60MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/16\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-11-16
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.